44th Parliament, 1st Session
(November 22, 2021 - Present)

Patented Medicine Prices Review Board

Report and Government Response

Report 17: The Patented Medicine Prices Review Board: Ensuring the Effectiveness of the Reform Process
  • Adopted by the Committee: April 18, 2024
  • Presented to the House: May 6, 2024
Report 17
Presented to the House: Monday, May 6, 2024
Government Response
Presented to the House: Monday, September 16, 2024

Please note that the committee is no longer accepting briefs in connection with this study.

Information

Meetings

Expand All Collapse All
3:53 p.m. - 5:56 p.m. (EST)
Studies and Activities
Notice of Meeting Minutes
11:01 a.m. - 12:14 p.m. (EDT)
Webcast
Studies and Activities
Watch Notice of Meeting Evidence Minutes
11:00 a.m. - 1:06 p.m. (EDT)
Webcast
Studies and Activities
Watch Notice of Meeting Evidence Minutes
Webcast Televised Audio only In Camera Cancelled Modified Outside of Parliament Hill

Related Information

Documents
Correspondence submitted by Mélanie Bourassa Forcier pursuant to the motion adopted by the committee on Thursday, May 4, 2023 Correspondence submitted by Douglas Clark pursuant to the motion adopted by the committee on Thursday, May 4, 2023 Correspondence submitted by the Department of Health pursuant to the motion adopted by the committee on Thursday, May 4, 2023 Correspondence submitted by Matthew Herder pursuant to the motion adopted by the committee on Thursday, May 4, 2023